Published

Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of psychopharmacology (Oxford, England)
Date: 2022-01-01
Source: PubMed
DOI: 10.1177/0269881120953994
PubMed: 33591231

Authors

Petranker R Anderson T Maier LJ Barratt MJ Ferris JA Winstock AR

Watch author

Derived topics and classifications

psilocybin Microdosing Creativity Observational Study Adverse Events Observational Study

Citation graph

0 referenced DOIs found in stored source metadata. 6 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults2026-10-01 The subtle science: a systematic review of psilocybin magic mushroom and truffle microdosing2026-08-19 Evaluating psilocybin for the management of depression: a literature review2026-08-02 Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development2026-07-03 Breaking the chains of depression: A systematic review and meta-analysis of psilocybin therapy2026-03-01 Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention.2022-01-01

Related papers

Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. AdultsAmerican Journal of Preventive Medicine · 2026-10-01 Therapeutic potential of classic and non-classic psychedelics in neurodevelopmental disorders: Opportunities and challenges.Pharmacological research · 2026-08-06 Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01 Contribution of the Serotonin 5-HT2A Receptor to the Therapeutic Effect of Psilocin on Social Behavior Deficits in Mice Repeatedly Exposed to Social Defeat StressNeuropsychopharmacology Reports · 2026-09-01 Adverse Effect-Related Language in Recreational Psychedelic and non-Psychedelic Substance Experience Reports.Journal of studies on alcohol and drugs · 2026-08-22 Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin ServicesJAMA Network Open · 2026-08-19 The Abuse Liability of Classic Psychedelics: A Methodological Critique and Assessment of the Quality of Evidence of Recent StudiesCurrent Addiction Reports · 2026-08-18 The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young AdultsClinicalTrials.gov · 2026-08-14